A microelectronic array assay was developed to specifically genotype Helicobacter pylori versus Helicobacter heilmannii and to determine antimicrobial resistance. Helicobacter 16S rRNA and 23S rRNA genes were specifically generated with Helicobacter genus-specific primers, respectively. The single-nucleotide polymorphisms (SNPs) in 16S rRNA, 268T specific in the H. pylori sequence, and 263A specific in H. heilmannii were used as molecular markers for identification of H. pylori and H. heilmannii, respectively. A triple-base-pair resistant mutation, AGA965-967TTC in 16S rRNA, is known to be responsible for H. pylori tetracycline resistance and was detected to identify resistant strains. H. pylori macrolide resistance was determined by the identification of 3 defined mutations in the 23S rRNA gene using the same method. The assay could be directly used to detect H. pylori in feces. The assay performs multiple determinations, including identification of Helicobacter species and antibiotic resistances, on the same microelectronic platform and is highly amenable to the development of other DNA-based assays. (Journal of Biomolecular Screening 2005:235-245) 
INTRODUCTION
N UCLEIC ACID-BASED ASSAYS have been proven to be adaptable for use in molecular laboratories and promise to be useful not only in diagnosis and patient management but also in epidemiological investigations and infection control. [1] [2] [3] [4] [5] Genotyping bacteria has been used to identify different species 5, 6 and to determine resistance to antimicrobial agents. 3, 4, 7 Providing complete information on the pathogen is important for epidemiological investigation, infectious disease control, prevention, clinical management, and prognosis. Bacterial identification and typing, as well as antimicrobial resistance, are fundamental elements in these processes. To achieve this purpose, a multiplex strategy (e.g., combining several different assays) is usually used to gather more complete information of the pathogens. It is difficult to find 1 single technology that fulfills all the requirements for bacterial identification. Therefore, developing a technique that can perform multiple determinations for bacterial identification and typing, as well as antimicrobial resistance, in the same platform would be optimal.
Two major Helicobacter species have been associated with human gastritis, peptic ulcer, and gastric carcinoma. 8, 9 Helicobacter pylori presents in 59% of human esophagogastroduodenal (EGD) endoscopy specimens. 10 Helicobacter heilmannii is relatively uncommon, with frequencies ranging between 0.25% and 1.7%. 10, 11 However, the frequency of H. heilmannii in domestic cats and dogs is as high as 80% to 100%. 12 With H. heilmannii, it has been postulated that, upon close contact with these animals, transmission to humans may occur. 13 Two distinct species could help to identify the reservoir. Particularly for the patient with Helicobacter infection and cats or dogs in the same household, bacterial examination should also be focused on H. heilmannii. 13 Although a number of assays are available for the determination of Helicobacter, a lingering debate of these testing technologies for Helicobacter in epidemiology is how to identify H. heilmannii and discriminate it from H. pylori. The optimal noninvasive testing approach for the identification of Helicobacter infection also remains controversial. [14] [15] [16] [17] [18] Clarithromycin, 1 macrolide antibiotic, is one of the most frequently used antibiotics for the treatment of H. pylori infection. Resistance to clarithromycin accounts for approximately 60% to 70% of treatment failures. 19 H. pylori clarithromycin resistance is associated with single-base mutations in the peptidyltransferase-encoding region of the 23S rRNA gene. [19] [20] [21] Three stable mutations have been reported and involve an A-to-G substitution at either position 2143 or 2144 (A2143G and A2144G) or an A-to-C substitution, also at position 2143 (A2143C) (complementary to positions of the Escherichia coli 16S rRNA gene: GenBank accession no. AB03592). These 3 substitutions account for more than 92% of macrolide resistance in H. pylori. 19, 20, 22 Tetracycline-based triple or quadruple therapies are often used as a 2nd-line treatment. The resistance of H. pylori to the recently available antibiotic treatment regimens has been a growing problem. Tetracycline-resistant strains are starting to emerge at a low rate, occurring in about 5% to 7% of isolates. [23] [24] [25] It was reported that a triple-base-pair resistant mutation, AGA965-967TTC, in the 16S rRNA (complementary to positions of the E. coli 16S rRNA gene) is able to confer tetracycline resistance to H. pylori. 23, 24 Microarray technologies are developed that use high-density olignucleotide captures to analyze hundreds to thousands of different loci simultaneously 26, 27 and have been widely used in scientific research. However, these technologies are not yet widely used in clinical settings. Previous studies have reported that a microelectronic chip array was used for analysis of single-nucleotide variations or gene mutations in either bacterial 7, 28, 29 or DNA repair gene human OGG1. 30 Here we describe a multiplex assay that is capable of discriminating H. pylori and H. heilmannii from other Helicobacter species that can also be used for the identification of H. pylori macrolides and tetracycline resistance simultaneously on the same microarray. 
MATERIALS AND METHODS

Bacterial strains and chemicals
PCR primers, specific probes, and universal reporter
All PCR reagents were obtained from Invitrogen (Burlington, ON, Canada). The PCR primers, specific probes, and universal reporter used in this study are listed in Table 1. A universal primer  pair (8F and 806R in Table 1) , designed from a highly conserved region in the 16S rRNA gene, was used to amplify the 16S rRNA gene for all 12 genera of bacteria. The specific primers HG16-Primer 221F for the 16S rRNA gene and HG23-Primer 2058F for the 23S rRNA were designed by choosing sequences that are conserved among 11 other important pathogenic bacteria responsible for food-or water-borne diseases. For single-nucleotide polymorphism (SNP) analysis, 1 pair of the sequence-specific stabilizer and reporter, which were complementary to the corresponding targets, was designed for each SNP or mutation, based on the manufacturer's instructions (Nanogen, Inc., San Diego, CA). 31 The stabilizers contained 20 to 24 nucleotides, which were designed to contain the sequence located at the immediate downstream of an SNP or mutation. A pair of reporters was designed to differentiate between the wild type and mutant of a specific allele. The fluorescent-labeled reporters contained 10 to 11 nucleotides and were located upstream of the SNP, including the mutation site (adjacent to the stabilizer). The PCR primers and stabilizers were synthesized by Invitrogen, and labeled primers and reporters were synthesized and purified using high-performance liquid chromatography (HPLC) by Integrated DNA Technologies (Coralville, IA).
Determination of specificity of Helicobacter genus-specific primer
The specificity of the Helicobacter genus-specific primer was determined with hybridization on the Nanogen chip array. The biotinylated Helicobacter genus-specific primer was used as a capture and immobilized on the chip surface that contained streptavidin. The 12 bacterial genera target PCR amplicons were then electronically delivered to designated spots. Nonspecifically bound targets were eliminated with thermal stringency by washing at 55°C. A Cy3-labeled reporter that universally binds to the 16S rRNA gene amplicon was used to report specific binding target DNA. The fluorescent signal in each pad was monitored after removing the report that was nonspecific binding to the microarray.
PCR amplification
16S rRNA and 23S rRNA gene segments were amplified individually. For each amplification reaction, negative controls containing water instead of template DNA were run in parallel. After the initial denaturation (94°C, 5 min), 25 cycles of amplification were carried out in a GeneAmp 9600 thermal cycler (PE Applied Biosystems, Boston, MA). Each cycle consisted of 1 min of denaturation at 94°C, 1 min of annealing at 55°C, and 1 min of extension at 72°C.
Detection of H. pylori DNA in human feces
Stool samples were obtained from 2 healthy volunteers known to be negative, as determined by the 13 C urea breath test. Spiking stool samples and removing PCR inhibitor were performed based on the description by Monteiro and others. 32 Briefly, the H. pyloriinfected stools were prepared by adding 20 µL of the H. pylori (HP 1204) suspension to 10 mg of each stool sample, that is, 5 × 10 8 CFU/g for a 10 8 -CFU/mL suspension. For all experiments, inoculated stool samples were always compared with noninoculated stool samples. DNA extraction was performed, and the PCR inhibitors present in stool samples were removed by pretreatment of DNA with an agarose-embedded DNA preparation. 32, 33 PCR was subsequently carried out using DNA-containing agarose slices as templates.
Template preparation
To desalt the PCR amplicons, 25 µL of PCR product was diluted to 75 µL with H 2 O and then run through Biospin columns (Bio-Rad, Mississauga, ON, Canada) according to the manufacturer's instructions. The amplicon was then prepared in 50 mM Lhistidine to make the final amplicon concentration to 50 nM. This solution was heated at 95°C for 5 min to denature the doublestranded amplicon and kept on ice before hybridization onto the chip. 268T (complementary to the position of E. coli) in the 16S rRNA gene ( Table 2 ). This SNP occurs in 34 of 35 H. pylori strain sequences available in GenBank (http://www.ncbi.nlm.nih.gov/ Genbank/) and was used as a molecular marker for identifying H. pylori ( Table 2) . One H. pylori strain (AF361935) has more than 40% sequence variation from the other 34 strains analyzed and does not have this SNP. The SNP 263A (complementary to the position of E. coli) appears only in the H. heilmannii sequence and not in other Helicobacter species (Table 2 ). This SNP occurs in all 31 H. heilmannii strains analyzed and was used as a molecular marker for identifying H. heilmannii. The intestinal pathogen Helicobacter bizzozeronii (AF302107), which is likely the same as H. heilmannii, 9 shares the same SNP 263A as H. heilmannii.
Polymorphisms in H. pylori and H. heilmannii
Principle of the assay
Initial procedures were performed as described in research application notes published by Nanogen. 31 Figure 1 shows the process for discrimination of Helicobacter species and macrolide resistance mutation by SNP analysis, as well as identification of H. pylori tetracycline resistance by dot blot hybridization. Electronic addressing was accomplished by applying voltage through a microelectrode that is connected to the specific spot. With electronic leading, the target DNA and stabilizers were addressed to the designated spots ( Fig. 2A) .
SNP analysis was used to discriminate single-base variation. The process involved 3 steps: immobilization of biotinylated amplicons, hybridization with stabilizer, and detection of reporter fluorescence (Fig. 2B ). The solutions of each biotinylated amplicon (50 nM) prepared in 50 mM L-histidine were electroni-cally delivered to defined locations on a Nanogen chip using an alternating current (AC) of 0.8 µA/pad for 25 s with cycles of 38-µs positive bias and 25-µs negative bias. The biotinylated amplicon was immobilized on a chip surface that contained streptavidin. After amplicons were loaded on the designated spots, stabilizer was electronically hybridized to the selected sites under AC conditions of 1.6 µA/pad (19 µs positive, 12 µs negative) for 3 min. Sites on the Nanogen chip were also biased with only 50 mM L-histidine to serve as background controls. The chip was washed with high salt buffer (50 mM NaPO 4 , pH 7.0, 500 mM NaCl). Base-stacking reporters were used such that the 5′ end of the labeled reporter would base stack alongside a longer stabilizer oligonucleotide, as previously described. 7 Wild-type reporters were labeled with Cy3 dye, and mutant reporters were labeled with Cy5. The ratio of the fluorescence signals (detecting Cy3 at λ ex 550 nm and λ em 568 nm; Cy5 at λ ex 650 nm and λ em 670 nm) was used to determine whether the target was wild type or mutant. Thermal stringency was performed to melt off any reporter oligo that was not specifically bound to the target.
Dot blot hybridization was used to identify tetracycline triplebase-pair resistant mutation. Compared with SNP analysis, the test did not need base-stacking energies because of the detection of multibase mutation. Therefore, the fluorescence-labeled specific probe was directly hybridized to the target amplicon without stabilizer. Thermal stringency and fluorescent signal monitoring were performed the same as SNP analysis.
The genotyping of a sample was based on the ratio of red and green fluorescence. A ratio of 1:1 (red to green) indicates the sample as heterozygous; ratios of >3:1 or 1:3 (red to green) identify the sample as homozygous (the mutant and wild-type alleles, respec- a. SNP 268T: complementary to position 268 bp of the 16S rRNA gene of E. coli (AB03592). SNP 268T was found in 34 of 35 H. pylori strains: AF302106, AF348617, AF361935, AF363064, AF512997, AF512997, AF535194, AF535195, AF535196, AF535197, AF535198, AY062898, AY062899, AY155587, HEC16SRA, HEC16SRB, HEC16SRC, HEC16SRD, HEC16SRE, HEC16SRF, HEC16SRG, HEC16SRI, HECRR16SAD, HP16SRRNF, HP16SRRNG, HPU00679, HPU08906, HPY310143, HPY310144, U01328, U01329, U01330, U01331, U01332. One H. pylori strain (AF361935) has more than 40% sequence variation from the other 34 H. pylori strains and does not have this single-nucleotide polymorphism (SNP). b. SNP 263A: complementary to position 263 bp of the 16S rRNA gene of E. coli (AB03592). SNP 263A was found in 31 of 31 H. heilmannii strains: AF506790, AF252625, AF506769, AF506791, AF506789, AF506788, AF506787, AF506773, AF506784, AF506771, AF506792, AF506781, AF506793, AF506782, AF506783, AF506780, AF506785, AF058771, AF506776, AF506777, AF506774, AF506778, AF506775, AF506779, AF506772, AF506770, AF506786, AF058768, AF506794, Y18028, AF506795. c. H. bizzozeronii is likely the same as H. heilmannii. tively). When ratios were between 1:2 and 1:3 or between 2:1 and 3:1, the test was repeated.
Reporter discrimination of SNPs
SNP 268T and SNP 263A in the 16S rRNA gene were used as molecular markers for H. pylori and H. heilmannii, respectively ( Table 2) , and determined by SNP analysis on the microelectronic array. Biotinylated Helicobacter amplicons were immobilized to the designed pads and analyzed for both SNPs on the same platform. When the target presented a perfect match to the labeled reporter, the base-stacking energies between the stabilizer oligonucleotide and the labeled reporter would be favorable, allowing the shorter reporter to remain hybridized to the target DNA at elevated temperatures. However, when a mismatch was presented in the target DNA, the base-stacking energy of the stabilizer oligonucleotide would be diminished, allowing removal of the la-beled reporter at elevated temperatures. Two reporters were designed to distinguish the SNPs.
Identifying H. pylori antimicrobial resistances
The H. pylori antimicrobial resistances were sequentially identified. The SNP 268T reporter was removed from the same amplicon of the 16S rRNA gene by thermal denaturation at 55°C (Fig. 1A, stage 3) after identification of H. pylori. Then, dot blot hybridization with sequence-specific probes was subsequently used to identify H. pylori tetracycline resistance with the same H. pylori target amplicon on the same platform (Fig. 1A, stage 4) . The specific probe HPTR-Pb-M965-967TTC with Cy3 labeling was designed for the detection of triple-base-pair TTC965-967 mutation, and the probe HPTR-Pb-W965-967AGA with Cy5 labeling was designed for wild-type AGA965-967 ( Table 1) was monitored after removing nonspecific binding by thermal stringency. Three stable single-base mutations in the 23S rRNA gene (A2143G, A2144G, and A2143C) are associated with clarithromycin resistance in H. pylori. These mutations were detected by mutation analysis on the chip. After the H. pylori 23S rRNA gene was generated with Helicobacter-specific primers, the biotinylated target amplicon was addressed on the chip, and mutations were detected by mutation discrimination analysis (the same principle as SNP analysis). This determination was simultaneously performed on the same platform (Fig. 1A, stage 4) .
RESULTS AND DISCUSSION
Specificity and sensitivity
When the 16S rRNA gene sequence is used, a genus-specific PCR primer pair was simple to design and was used for the generation of PCR products for all Helicobacter species. The specificity of the Helicobacter genus primer was determined by dot blot hybridization on the microelectronic chip array. In this test, the biotinylated genus primer, HG16-Primer 196F, was first used as a capture probe and electronically addressed to designed pads on the array. Twelve different genus bacterial amplicons, generated by 1 pair of universal primers (Table 1) , were then addressed to different pads, respectively. Figure 3A shows the pattern of fluorescence on the microelectronic array used for the identification of the Helicobacter genus. The assay can differentiate Helicobacter from 11 other pathogenic bacteria found in food-or water-borne diseases. In 12 different bacterial genera targets, only the H. pylori amplicon responded to the site on the microarray chip, where a Helicobacter genus-specific probe was preaddressed, and no false-positive results were shown in the other 11 bacterial amplicons. HG16-Primer 196F was also used to detect all Helicobacter species, including DNA of H. pylori and H. heilmannii generated from either standard culture or agaroseembedded DNA blocks of the stool samples, and no false-negative results were generated.
The sensitivity of the PCR was evaluated by amplification of several 10-fold dilutions of DNA from the H. pylori HP 1204 (starting with a template concentration of 10 ng/µL, in water). The detection limit was 0.2 pg/µL, regardless of the DNA extraction method with or without agarose slices.
The interference of feces was also evaluated. Because the PCR inhibitors present in stool samples could lead to a negative result, the eluate obtained after DNA extraction was used to prepare agarose-embedded DNA blocks to remove the inhibitors. 32 Figure  3B shows that a weak PCR bind in sample A and no PCR products in sample B were generated when DNA was prepared without agarose-embedding. When PCR was carried out on DNA-containing agarose slices, PCR products for both samples were obtained (Fig. 3B ). This demonstrated that PCR inhibitors present in original DNA samples, which can inhibit PCR amplification, could be removed by agarose-embedded DNA preparation. The sensitivity of PCR was 5 × 10 7 CFU/g, which is similar to what has been reported. 32 However, to generate enough target amplicon for the microarray, at least 10 8 CFU/g is needed.
Stool specimens constitute a sample of easy, noninvasive access and consequently are of high potential interest for the development of a direct method of H. pylori detection. In this study, with agarose-embedded DNA blocks to prepare the PCR amplicon, a microelectronic array could be used to detect H. pylori in the feces sample directly. Although the sensitivity of the test was relatively low, the test could simultaneously identify H. pylori in the feces sample and provide additional information, particularly that related to pathogenicity factors or antibiotic resistance, such as macrolides and tetracycline.
Identification of Helicobacter species
DNA SNP variation analysis was used to identify H. pylori and H. heilmannii on the microarray (Fig. 4) . SNP 268T, which only shows in the H. pylori 16S rRNA gene ( Table 2) , was used as a molecular marker for the identification of species of H. pylori. A typical confocal fluorescent image of a microelectronic chip for the analysis of SNP C268T in the 16S rRNA gene of H. pylori as a model is shown in Figure 1B . To identify the single-nucleotide difference between the wild type (C268, no mutation at this position) and the mutant (268T, a change of a single nucleotide), we used a red reporter (Cy5) that was complementary to the mutant and a green reporter (Cy3) that was complementary to the wild-type nucleotide. The green Cy3 fluorescent image confirms the presence of the wild-type sequence on pads (A,2), (B,2), and (C,2) on which only wild-type amplicon was loaded (Fig. 1B) . The mutant amplicon was delivered to positions (A,3), (B,3), and (C,3). The red fluorescent images from these positions are consistent with the presence of mutant. As expected, triplicate analyses of the heterozygote that was delivered to positions (A,4), (B,4), and (C, 4) show the presence of both red and green fluorescent images. These results indicated that an SNP could be determined by monitoring the 2 fluorescent signals that correspond to each specific reporter at each position of the microarray. The excellent specificity, as shown above for SNP analysis, was obtained by carefully designing the fluorescent reporters and by optimizing the stringency conditions. Figure 4A and B show the pattern of SNP 268T analysis of Helicobacter target amplicons on the electronic microarray. As expected with our SNP 268T analysis assay (Fig. 4A) , the amplicons for all 3 strains of H. pylori with SNP 268T showed red Cy5 fluorescence, H. heilmannii showed no fluorescence, and Helicobacter wild-type control sequence with 268C showed green Cy3 fluorescence. Similarly, SNP 263A was used as a molecular 
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marker for the identification of species of H. heilmannii. The amplicon of H. heilmannii with SNP 263A showed red Cy5 fluorescence ( Fig. 4C ), 3 H. pylori strains showed no fluorescence, and the wild-type sequence control with 263T showed green Cy3 fluorescence (Fig. 4D) . Species identification is an important but unresolved issue in most currently available noninvasive diagnostic tests for H. pylori (e.g., enzyme-linked immunosorbent assay [ELISA], Urease testing, and HpSA antigen detection). 9 It was reported that PCR was used to identify H. pylori. 32 However, additional tests were needed to provide other pathogenic information, such as antibacterial resistance. This report describes a specific assay that can be used for the direct discrimination of H. pylori and H. heilmannii, as well as identification of H. pylori antibiotic resistance, in the same test that facilitates treatment for these human pathogens. Furthermore, the method can be adapted for analysis of other human disorders and SNPs.
Detection of H. pylori macrolide and tetracycline resistance
The SNP 268T reporter was washed out by microelectronic thermal stringency after H. pylori was identified with SNP analysis on the Nanogen chip. We performed dot blot hybridization to detect the known tetracycline resistance mutation on the same amplicon with sequence-specific probes labeled with Cy3 and Cy5 separately (Fig. 5) . The triple-base-pair substitution AGA 965-967 → TTC (corresponding to the position of E. coli 16S rRNA) was used as a marker. We used a red reporter (Cy3) that was complementary to the mutant, and a green (Cy5) reporter was complementary to the wild-type nucleotide. The tetracycline resistance mutation TTC 965-967 in H. pylori responded to the specific probe (green fluorescent signal-Cy3, Fig. 5B ), and the wild-type H. pylori AGA 965-967 responded to the wild-type probe (red fluorescent signal-Cy5, Fig. 5A ). Using these specific probes, the microarray assay was simple while specifically and accurately identifying the tetracycline resistance mutation in H. pylori.
Discrimination between the known clarithromycin resistance mutations (A2143G, A2144G, and A2143C) and nonmutants in the 23S rRNA gene was performed using the same process as described above in the SNP analysis. Our analysis correctly identified the single-nucleotide difference between the mutation and wild-type alleles in all 3 types of clarithromycin resistance muta- Figure 6A to C shows the green and red fluorescence intensities from the analysis for all 3 types of mutations: A2143G, A2144G, and A2143C. Genotypes of the 3 types of mutations were identified based on the ratios of fluorescence signals. The mutations of A2143G, A2144G, and A2143C were identified by the Cy5/Cy3 ratio of 68.5, 22.9, and 23.6, respectively, in resistance strains (Fig. 6) . The wild type of A2143A and A2144A was identified by the Cy3/Cy5 ratio of 10.4 and 20.5, respectively. Conventional antimicrobial susceptibility testing takes a long time because Helicobacter grows slowly. 3 Simultaneous identification of Helicobacter species and the determination of antibiotic resistance with this technology will drastically reduce the time required for analysis. The determination of resistant mutations can potentially be used for studying nosocomial infections when applied in the context of an epidemiological investigation. Although H. pylori is susceptible to a wide range of antimicrobial agents in vitro, this does not translate into in vivo efficacy, and eradication requires the use of combinations of antimicrobial agents (including metronidazole and lactams). Furthermore, the detection of antimicrobial resistance for metronidazole and lactams should be included in the assay. Figure 1 demonstrates that the microelectronic array could be performed with different hybridization events on a single assay. SNP analyses for single-base substitution and dot blot hybridization for multibase mutation could be performed using the same target DNA amplicon (e.g., identification of H. pylori and tetracycline resistance using the same 16S rRNA gene fragment). The multiple SNP analyses were also performed to different target amplicons. In this study, we identified H. pylori or H. heilmannii from other Helicobacter species simultaneously. SNP analyses and identification of H. pylori resistance in the same test gave an example that the microelectronic array could be used to perform multiple tests with a different purpose in the same platform.
Multiple analyses on Nanogen microarray
Clinical and epidemiological studies needs complete information on the Helicobacter pathogen. However, bacterial typing is often difficult based on limited information due to the difficulty of performing multiplex reactions in 1 single test. Most of the currently available genotyping techniques for Helicobacter (e.g., PCR) just provided single information. To get more complete information, other techniques are needed. Traditional DNA microarray was limited for clinical study because it only worked in simple hybridization events. With the electronic guide addressing target amplicon or probes onto the designed pad, the microelectronic array could be used to perform a number of different hybridization events on a single analytical surface, thereby overcoming the limitations of the most commonly used oligonucleotide-based DNA detection methodologies. In this study, we have demonstrated an assay that can simultaneously identify H. pylori, H. heilmannii, and H. pylori resistance to tetracycline and macrolides in 1 test. It provided more complete information on the pathogen and bacterial identification and antimicrobial resistance in the shorter test period. The combination of multiple analyses in the same platform improved the discriminating power and provides an example of how to perform multiple-layer analysis on 1 single platform.
CONCLUSIONS
We have demonstrated a model assay for the multiple determinations of bacterial pathogens and antimicrobial resistance by using a microelectronic array. The microelectronic array approach combines DNA hybridization, electronic stringency, and SNP analysis to specifically identify Helicobacter species and obtain antibiotic resistance information simultaneously. The assay could be directly used to detect H. pylori in feces. The technique provides a useful tool to identify H. pylori and H. heilmannii for genotype investigation.
